BB Biotech AG Receivables is NA for the year ending August 18, 2025. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Competitors

Eli Lilly and Company

USD 701.23

LLY

+16.80 2.46%

AbbVie Inc.

USD 206.69

ABBV

+2.01 0.98%

Roche Holding AG

USD 331.61

RO.SW

+7.43 2.29%

Novartis AG

USD 123.29

NOVN.SW

+1.51 1.24%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novo Nordisk A/S

USD 50.97

NOVO-B.CO

+0.44 0.87%

Merck & Co., Inc.

USD 84.21

MRK

+1.45 1.75%

Thermo Fisher Scientific Inc.

USD 489.01

TMO

+3.97 0.82%

Amgen Inc.

USD 296.47

AMGN

+6.18 2.13%

Boston Scientific Corporation

USD 103.17

BSX

-0.98 -0.94%

Gilead Sciences, Inc.

USD 118.37

GILD

-0.65 -0.55%

Pfizer Inc.

USD 25.14

PFE

+0.03 0.12%

Sanofi

USD 99.43

SAN.PA

+2.12 2.18%

Vertex Pharmaceuticals Incorporated

USD 392.79

VRTX

+2.49 0.64%

Bristol-Myers Squibb Company

USD 48.44

BMY

+0.63 1.32%

View all

Key Data

Date	Receivables	Inventory	Current Assets	Property, Plant, Equipment (Net)